Litcius/Paper detail

Region-Specific and Age-Dependent Multitarget Effects of Acetylcholinesterase Inhibitor Tacrine on Comprehensive Neurotransmitter Systems

Elva Fridjonsdottir, Theodosia Vallianatou, Ioannis Mantas, Mohammadreza Shariatgorji, Anna Nilsson, Luke S. Schembri, Luke R. Odell, Per Svenningsson, Per E. Andrén

2021ACS Chemical Biology28 citationsDOIOpen Access PDF

Abstract

Regional brain distribution and metabolism of neurotransmitters and their response to drug treatment are fundamentally important for understanding the central effects of neuroactive substances. We used matrix-assisted laser desorption/ionization mass spectrometry imaging in combination with multivariate analysis to visualize in anatomical detail metabolic effects of aging and tacrine-mediated acetylcholinesterase inhibition on comprehensive neurotransmitter systems in multiple mouse brain regions of 12-week-old and 14-month-old mice. We detected age-related increases in 3,4-dihydroxyphenylacetaldehyde and histamine, indicating oxidative stress and aging deficits in astrocytes. Tacrine had a significant impact on the metabolism of neurotransmitters in both age groups; predominantly, there was an increased norepinephrine turnover throughout the brain and decreased 3-methoxy tyramine, a marker for dopamine release, in the striatum. The striatal levels of histamine were only elevated after tacrine administration in the older animals. Our results demonstrated that tacrine is a multitarget and region-specific neuroactive agent, inducing age-specific responses. Although well-studied, the complete mechanisms of the action of tacrine are not fully understood, and the current findings reveal features that may help explain its treatment-related effectiveness and central side effects.

Topics & Concepts

TacrineNeurotransmitterDopamineHistamineAcetylcholinesterasePharmacologyChemistryStriatumTyramineCholinergicInternal medicineEndocrinologyNeuroscienceCentral nervous systemMedicineBiologyBiochemistryEnzymeCholinesterase and Neurodegenerative DiseasesNicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology Research